CTX001
VX18-CTX001-131
Phase 3 mab active
Quick answer
CTX001 for Beta-Thalassemia is a Phase 3 program (mab) at CRISPR Therapeutics AG with 3 ClinicalTrials.gov record(s).
Program details
- Company
- CRISPR Therapeutics AG
- Indication
- Beta-Thalassemia
- Phase
- Phase 3
- Modality
- mab
- Status
- active